The QualityStocks Daily Tuesday, November 9th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(AMIH) $0.1090 +70.31%

Kiplinger Today(RBLX) $109.5200 +42.23%

Trades Of The Day(NEWR) $125.9700 +38.52%

The QualityStocks Daily Stock List

World Series of Golf (WSGF)

QualityStocks and Stock Guru reported earlier on World Series of Golf (WSGF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

World Series of Golf Inc. (OTC: WSGF) is a sports entertainment firm that helps manage and host amateur golf events and tournaments.

The company has its headquarters in Las Vegas, Nevada and was incorporated in 2006, on June 30th. It has a few subsidiaries, among them, L.A.X. Innovations Inc. and World Series of Golf Online Inc. The company operates in the online games and gaming industry as well as the sports and entertainment industry and provides its services to consumers across the globe.

The firm is focused on creating entertainment, media, games and branded products which are based off of its golf tournament method of play, dubbed The World Series of Golf by the company. Apart from broadcasting the tournaments it holds as live events on other media outlets as well as on television, the company also organizes bet amateur hole-by-hole hit prize tournaments, which are played on a professional 18-hole golf course.

As of January 2020, the firm had completed its acquisition of Vaycaychella LLC, which facilitates the renovation and purchase of real estate properties, with the intention of generating revenue from vacation rentals. The firm’s objective is to serve investors and vacation rental owners, having recently announced that they’d be launching their peer to peer alternative real estate investment app, which is currently under development, soon. It also plans on introducing additional applications which offer ancillary services to investors and vacation rental owners in the long term, which will push up the company’s stock prices.

World Series of Golf (WSGF), closed Tuesday's trading session at $0.0161, up 36.4407%, on 89,165,009 volume with 1,875 trades. The average volume for the last 3 months is 89.165M and the stock's 52-week low/high is $0.0051/$0.093.

SunHydrogen (HYSR)

QualityStocks, Investor News Source, Stock Preacher, Beacon Equity Research, InvestorPlace, OTC Picks, StockHideout, Penny Stocks Finder, MicroStockProfit, PennyTrader Publisher, InvestorSoup, SmallCapStockPlays, TheLightningPicks, OTCPicks, Wallstreetlivechat, Stock Roach, OTCReporter, Hotstocked, Wise Alerts, Penny Stock Finder, Investors Online Bell,, FeedBlitz, Top Stock Picks,,,, Greenbackers,, Crazy Carl,,, LightningStockPicks, Nebula Stocks, AimHighProfits,, Penny Stock Craze, Pumps and Dumps, Real Pennies,, Stockpalooza, TheMicrocapNews, TopPennyStockMovers and reported earlier on SunHydrogen (HYSR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sunhydrogen Inc. (OTC: HYSR) is focused on generation and marketing of renewable energy and is engaged in the provision of renewable energy services.

The company is based in Santa Barbara, California and incorporated in 2009, on February 18th. It serves consumers in the state of California. Prior to its name change, the firm was known as Hypersolar Inc.

SunHydrogen caters to metal processing, ammonia production, refineries and other sectors and produces economical renewable hydrogen using sunlight. It has developed a nanoparticle system that’s solar-powered and imitates photosynthesis to separate hydrogen from water. It plans to get this system’s technology to be licensed, allowing it to be used in producing renewable hydrogen and electricity for fuel cells. It generates energy from sunlight.

Its technology, the HyperSolar H2Generator, is used to develop a submersible hydrogen production particle which splits H2O molecules under the sun. Every particle is a complete hydrogen generator and contains a high voltage solar cell that’s bonded to chemical catalysts via an encapsulation coating. It is also developing a modular system that will allow for the daily production and storage of hydrogen that can be used at any time in the manufacture of fertilizer, oil and gas refining, the generation of electricity and any other hydrogen applications.

The company recently appointed a new Board Director and Chief Operating Officer, who has under his belt years of experience and is known for his strategic approach and leadership in operations management. This move will aid in the expansion of the firm’s brand footprint and global relationships, which will bring in investments.

SunHydrogen (HYSR), closed Tuesday's trading session at $0.088, up 23.7693%, on 46,802,560 volume with 2,025 trades. The average volume for the last 3 months is 46.803M and the stock's 52-week low/high is $0.02376/$0.3389.

American International Holdings Corp. (AMIH)

We reported earlier on American International Holdings Corp. (AMIH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American International Holdings Corp. is a diversified holding company listed on the OTC Markets. Its commitment is to acquiring, managing, and operating health, wellness, beauty, and lifestyle companies, businesses and/or brands located in the U.S. and internationally. The Company looks for opportunities to acquire and grow businesses that have strong brand values and that can produce long-term sustainable free cash flow and attractive returns to maximize value for American International and its stakeholders. Incorporated in 1986, American International Holdings has its corporate headquarters in Addison, Texas.

American International owns and operates a medical spa under the Novopelle brand name in McKinney, Texas. It also has its wholly-owned subsidiary, Capitol City Solutions USA, Inc. (CCS). CCS was formed to act as a general contracting and construction company centered on the remodeling, general construction, and interior finish of American International’s Novopelle branded med spa locations, as well as to market to other commercial real estate projects within the United States.

American International Holdings’ wholly-owned subsidiary, Novopelle Waterway, Inc. officially opened the doors to its Novopelle Med Spa located at the award-winning Woodlands Waterway in The Woodlands, Texas, on Tuesday, February 25, 2020. This is the second Novopelle Med Spa location to be established and operated by the Company.

American International Holdings’ dedication is also to operating and managing an online platform providing customers with access to life and career coaches via LifeGuru, Inc. (, which is now in development). Moreover, its dedication is to operating and managing an online telemedicine platform connecting customers to Board certified physicians and licensed mental and behavioral health counselors via ZipDoctor, Inc. (

American International Holdings previously announced that it has retained the services of Captify Consulting to lead, support, as well as champion the ZipDoctor’s digital marketing and social media advertising efforts as it relates to its recently launched subscription based online telemedicine platform, located at ZipDoctor’s online telemedicine platform is available to customers throughout the U.S. It offers bilingual coverage (English and Spanish), with virtual visits taking place either through the phone or via a secured video chat platform. Captify specializes in helping B2C (Business 2 Consumer) companies, eCommerce Brands, and entrepreneurs scale and boost their revenue with highly-targeted, consistently-converting digital advertisement campaigns.

American International Holdings Corp. (AMIH), closed Tuesday's trading session at $0.109, up 70.3125%, on 2,113,100 volume with 312 trades. The average volume for the last 3 months is 2.113M and the stock's 52-week low/high is $0.0503/$0.58.

Brazil Minerals (BMIX)

SmallCapVoice, Greenbackers, SmallCapStockPlays, QualityStocks, AllPennyStocks, Pumps and Dumps, PennyStocks24, OTPicks, Shiznit Stocks, Otcstockexchange, Fast Money Alerts, MassiveStockProfits, MicroCapINPLAY, PennyStocks Forever, WhisperFromWallStreet, Stock Shock and Awe, Whisper from Wall Street and Penny Stock General reported earlier on Brazil Minerals (BMIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Brazil Minerals Inc. (OTCQB: BMIX) is a mineral exploration firm that is engaged in the exploration for deposits of sand, cobalt, nickel, iron, titanium, rare earth metals, lithium, diamonds and gold in Brazil.

The firm has its headquarters in Pasadena, California and was incorporated in 2011, on December 11th. It operates in the materials sector, under the metals and mining sub-industry.

The enterprise has interests in gold via a minor position in Jupiter Gold Corp., which is developing a quartz mine and two gold projects and in iron via a majority position in Apollo Resources Corp. which is developing an iron mine, as well interests in various rare earth minerals, titanium and lithium projects. The enterprise also sells sand for use in construction and owns mining concessions for gold and alluvial diamond.

The company is involved in the development of two hard-rock lithium projects, the Pindaiba project, Jequitinhonha project and other projects in minerals like nickel, cobalt, manganese and diamonds. It also owns Hercules Resources Corp and BMIX Participacoes Ltda; which is based in Beverly Hills, CA, among others. The company’s assets include a promising gold producing area found in the Amazonas state which is known as Borba and an operating gold and diamond mine known as Duas Barras, which is found in the Minas Gerais state. Its other interests are found in the states of Piaui, Bahia, Tocantins, Paraiba, Rio Grande do Norte, Minas Gerais and Goias. More than 90% of the diamonds mined from Duas Barras are of quality for jewelry applications.

The firm recently announced that it would soon begin its first lithium drilling campaign, with the results expected to enable an initial technical report to be drawn up. The success of this campaign will allow mining and extraction for the sought after metal to begin, which would increase the firm’s revenues significantly.

Brazil Minerals (BMIX), closed Tuesday's trading session at $0.0114, up 28.234%, on 35,315,735 volume with 404 trades. The average volume for the last 3 months is 35.256M and the stock's 52-week low/high is $0.0007/$0.10.

Bit Brother (BTB)

QualityStocks and InvestorPlace reported earlier on Bit Brother (BTB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bit Brother Limited (NASDAQ: BTB) (FRA: 29D) is a specialty chemical firm that is involved in the production and distribution of organic compounds.

The firm has its headquarters in Changsha, the People’s Republic of China and was incorporated in 2011, on November 28th. Prior to its name change in May 2021, the firm was known as Urban Tea Inc. It operates as part of the consumer staple products industry, under the consumer staples sector, in the beverages sub-industry.

The company, which is also involved in the specialty tea product retail and distribution business, markets its products through wholly owned subsidiaries. It provides pastries which include frosting cakes, freshly baked cakes and freshly baked bread; light meals like burritos, steak, pasta, sandwiches and salads, as well as other healthy options and tea-based beverages, which include milk cap tea, fruit tea and fresh milk tea, among others. The enterprise also produces para-chlorotoulene (PCT), ortho-chlorotoluene (OCT) and unsaturated polyester resin (UPR) products. UPR products can be used in manufacturing materials for trains, cars, aircrafts and vessels. Its organic compounds are used in the food additive, clean energy, coating-printing, ceramics, aerospace, dye and pigments, agrochemical, pharmaceutical and automotive industries.

The enterprise plans to acquire a share of Angelo’s Pizza 1697 Inc., which has been around for over a century. This move will have a positive effect on the growth of both companies and allow Bit Brother to actualize its plans to expand into a restaurant while it continues to grow its Bitcoin payment business.

Bit Brother (BTB), closed Tuesday's trading session at $1.61, up 27.7778%, on 30,542,640 volume with 49,490 trades. The average volume for the last 3 months is 29.244M and the stock's 52-week low/high is $0.7421/$6.6924.

Protocall Technologies (PCLI)

Stock Traders Chat, OTC Picks, Stock Source, PennyTrader Publisher, OTCPicks, MicrocapVoice and FeedBlitz reported earlier on Protocall Technologies (PCLI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Protocall Technologies Inc. (OTC: PCLI) is focused on designing, developing, building, owning and operating commercial and residential real estate for its clients, portfolio or as joint ventures.

The firm has its headquarters in Panama City Beach, Florida and was incorporated in 1992. The firm has ten companies in its corporate family and serves consumers around the globe.

The enterprise is involved in the active development of various lots for residential real estate. It is also developing commercial real estate and infrastructure for lease to Bitcoin mining operations. In addition to this, the enterprise is focused on the development and commercialization of its electronic sell-through platform which allows retailers to produce video game, consumer software and DVD movie products in retail packaging at their website and store distribution centers. It provides its TitleMatch DVD on-demand product which provides retailers with a virtual inventory of digital media products which can be produced on-demand. This eliminates the cost of physical inventories and helps save on expenses. The enterprise also uses its solutions to offer outsourced fulfillment services to web retailers. This entails digital media product orders being electronically routed to the firm for on-demand production and shipment to the customer of a retailer. Additionally, it offers electronic merchandising, digital rights management and programming services to software publishers and its online and retail customers.

The company is focused on significantly expanding its asset portfolio through acquisitions and the vertical integration of different private real estate LLCs. It recently acquired a real estate development firm known as JR Development LLC. This move positions the company to profit from the change of value created by its commercial and residential land developments.

Protocall Technologies (PCLI), closed Tuesday's trading session at $0.0041, off by 4.6512%, on 3,844,212 volume with 56 trades. The average volume for the last 3 months is 3.844M and the stock's 52-week low/high is $0.0004/$0.0081.

Liquid Avatar Technologies (LQAVF)

We reported earlier on Liquid Avatar Technologies (LQAVF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Liquid Avatar Technologies Inc. (OTCQB: LQAVF) (FRA: 4T5) is focused on the management, monetization and verification of digital identity.

The firm has its headquarters in Markham, Canada and was incorporated in 2014, on September 10th. Prior to its name change, the firm was known as KABN Systems NA Holdings Corporation. It serves consumers across the globe.

The company believes that the ownership of one’s identify is a basic human right and that people should be the primary beneficiary of any use of their identity. This is why it enables users to create digital icons which they can use to represent their online persons, through its Liquid Avatar program.

The enterprise’s products include a biometric and block-chain based digital identity verification and validation platform known as KABN ID, which enables users to prove themselves throughout the online community. It offers a prepaid card program that is Visa approved dubbed the KABN Card, which allows users to manage both fiat and digital currencies and earn loyalty incentives. It also provides its Liquid Avatar program, as mentioned above, which also enables users to share both private and public authenticated information online when they want, with whom they want and how they want. In addition to this, the enterprise offers KABN Kash, which is an engagement, loyalty and cashback program which powers its revenue ecosystem.

The company recently entered into an agreement with Optimize Fintech Technology to launch a neobanking and fintech solution for its mobile app, which will mainly serve consumers in the U.S. market. The neobank and alternative banking market is experiencing significant growth, which positions the firm well to grow and also expand into new markets.

Liquid Avatar Technologies (LQAVF), closed Tuesday's trading session at $0.1744, off by 5.7297%, on 173,439 volume with 52 trades. The average volume for the last 3 months is 173,439 and the stock's 52-week low/high is $0.0427/$0.41976.

Applied Optoelectronics (AAOI)

Zacks, StocksEarning, MarketBeat, MarketClub Analysis, Schaeffer's, InvestorPlace, StreetInsider, The Street, Barchart, StockMarketWatch, Kiplinger Today, The Online Investor, Daily Trade Alert, Investment House, Profit Confidential, The Best Newsletters, BUYINS.NET, Trades Of The Day, Hit and Run Candle Sticks, Louis Navellier, TraderPower, Investopedia, InvestmentHouse, Investment U, Rick Saddler, Market Report, Investing Futures, Investing Signal,, Short Term Wealth, The Stock Dork and Market Intelligence Center Alert reported earlier on Applied Optoelectronics (AAOI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Applied Optoelectronics Inc. (NASDAQ: AAOI) (FRA: A59) is focused on designing, manufacturing and selling different fiber-optic networking products.

The firm has its headquarters in Sugar Land, Texas and was incorporated in 1997, on February 28th by Chih Hsiang Lin. It serves consumers across the globe, with a focus on the United States, the People’s Republic of China and Taiwan.

The company operates in Taipei, Ningbo and Taiwan and China, via its wholly owned subsidiary known as Prime World International Holdings Limited. This subsidiary operates a branch in Taipei, Taiwan, which is mainly involved in the manufacture of transceivers. It also conducts research and development activities for its transceiver products. In addition to this, the company has a research and development facility in the state of Georgia. Its customers include Microsoft, Facebook, Amazon, Cisco Systems and Arris Group. The company generates the majority of its revenue from Taiwan and China.

The enterprise uses its Molecular Beam Epitaxy fabrication process to manufacture its products, which include transceivers, transmitters, turn-key equipment and optical devices like photodiodes, subassemblies and laser diodes, as well as distribution, node and headend equipment, which allow for faster connections. It sells its products through indirect and direct sales channels. The enterprise serves the telecom equipment manufacturer, fiber-to-the-home, Cable Television Broadband and internet data center markets.

The firm recently released its financial results for the third quarter of 2021, with its CEO noting that they had observed an improvement in Datacom. Currently, the firm is focused on growing its CATV business.

Applied Optoelectronics (AAOI), closed Tuesday's trading session at $5.75, off by 1.7094%, on 1,237,954 volume with 10,320 trades. The average volume for the last 3 months is 1.238M and the stock's 52-week low/high is $5.61/$13.9488.

American Bio Medica (ABMC)

MarketBeat, BUYINS.NET and reported earlier on American Bio Medica (ABMC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Bio Medica Corporation (OTCQB: ABMC) is a biotechnology firm that is focused on the development, manufacture and sale of lateral flow immunoassay tests, which are mainly used to detect drugs in oral fluids and urine.

The firm has its headquarters in Kingerhook, New York and was incorporated in 1986, on April 2nd by Edmund M. Jaskiewicz and Stan Cipkowski. Prior to its name change in September 1992, the firm was known as American Micro Media Inc. It operates as part of pharmaceutical and medicine manufacturing industry and serves consumers around the globe.

The company mainly operates in the United States and the wider North American region, as well as South America, the Asia Pacific, Africa and Europe. Its target consumers include the educational, clinical, corrections, government and workplace markets. The company generates most of its revenue from the U.S.

The enterprise’s products include a drug testing cup dubbed Rapid TOX Cup II, which detects the absence or presence of 1-16 drugs; a drug test in a cassette platform known as Rapid TOX, which detects the absence or presence of 1-10 drugs; a drug testing cup dubbed RDS InCup, which detects the absence or presence of 1-12 drugs; and a rapid drug test known as Rapid Drug Screen, which detects the absence or presence of 2-10 drugs. It also provides a drug test known as OralStat, which detects drugs in oral fluids. In addition to this, the enterprise offers bulk test strip contract manufacturing services to various diagnostic firms.

The company is currently focusing its efforts on obtaining more contract manufacturing accounts. This will help extend its consumer reach, bring in additional revenue into the company as well as encourage more investments into the company, which will be good for its growth.

American Bio Medica (ABMC), closed Tuesday's trading session at $0.04675, off by 9.9229%, on 548,233 volume with 63 trades. The average volume for the last 3 months is 548,233 and the stock's 52-week low/high is $0.0316/$0.29.

Puma Biotechnology (PBYI)

The Street, StocksEarning, StreetInsider, InvestorPlace, MarketBeat, Schaeffer's, MarketClub Analysis, Money Morning, StockMarketWatch, Real Pennies,, StreetAuthority Daily, BUYINS.NET, Kiplinger Today, The Weekly Options Trader, Daily Trade Alert, Zacks, QualityStocks, Barchart, TopStockAnalysts, Weekly Wizards, TraderPower, CustomerService, Profit Confidential, Trades Of The Day, CRWEFinance, CrashTrade, Hit and Run Candle Sticks, CRWEPicks, DrStockPick, CRWEWallStreet, BestOtc, Investing Futures, Investopedia, BestChartNow, InvestorsUnderground, Market Intelligence Center, Market Intelligence Center Alert, PennyToBuck, Rick Saddler, Schaeffer’s, StockEarnings, StockHotTips, Stocks To Watch, Streetwise Reports, SwingTradeOnline, The Online Investor, Wealth Insider Alert, WStreet Market Commentary and PennyOmega reported earlier on Puma Biotechnology (PBYI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Puma Biotechnology Inc. (NASDAQ: PBYI) is a biopharmaceutical firm that is engaged in developing and commercializing products that improve cancer care.

The firm has its headquarters in Los Angeles, California and was incorporated in 2010, on September 15th by Alan H. Auerbach. It operates as part of the pharmaceutical and medicine manufacturing industry and serves consumers around the globe. The firm has three companies in its corporate family.

The company operates through its subsidiaries, i.e. Puma Biotechnology B.V. and Puma Biotechnology Ltd. It is focused on in-licensing drug formulations which have already concluded or are undergoing initial clinical testing for the treatment of cancer. The company plans to further develop these formulations for commercial use. It is party to sub-license agreements with Bixink Therapeutics Co. Ltd, Pierre Fabre Medicament SAS, Knight Therapeutics Inc., Pint Pharma International S.A., Canbridge Biomed Ltd and Specialized Therapeutics Asia Pte Limited. It is also party to a license agreement with Pfizer Inc.

The enterprise’s product pipeline comprises of a formulation dubbed PB272, which has been developed for HER2 mutation-positive solid tumors. This formulation is also indicated for the adjuvant treatment of adults with early stage HER2-amplified/overexpressed breast cancer. In addition to this, the formulation is also indicated for use in combination with capecitabine for the treatment of metastatic or advanced HER2-positive breast cancer.

The firm’s PB272 formulation recently received regulatory approval in South Korea. The enterprise is now planning to meet with the FDA to discuss accelerated approval for the formulation in the treatment of HER2-mutated hormone receptor positive breast cancer. The approval of this formulation in the U.S. would not only offer support to patients battling breast cancer but also bring in more investments into the firm, which would be good for its growth.

Puma Biotechnology (PBYI), closed Tuesday's trading session at $3.8, off by 4.5226%, on 979,782 volume with 7,154 trades. The average volume for the last 3 months is 979,782 and the stock's 52-week low/high is $3.80/$14.14.

Workhorse Group Inc. (WKHS)

Green Car Stocks, InvestorPlace, MarketClub Analysis, Schaeffer's, Kiplinger Today, MarketBeat, QualityStocks, StockMarketWatch, StreetInsider, TradersPro, The Street, Trades Of The Day, StocksEarning, Daily Trade Alert, TraderPower, TopPennyStockMovers, BUYINS.NET, Wealth Insider Alert, Early Bird, Zacks, InvestorsUnderground, Jason Bond, Cabot Wealth, PoliticsAndMyPortfolio, StockOodles, The Online Investor,, Profitable Trader Authority, The Wealth Report, Wealth Daily, Stock Beast, Energy and Capital, The Best Newsletters and Daily Market Beat reported earlier on Workhorse Group Inc. (WKHS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The age of the electric vehicle (“EV”) is nigh. All around the world, drivers are becoming increasingly interested in these zero-emission vehicles because of their environmental benefits and the long-term cost savings they offer. The fact that automakers are consistently working to develop superior EVs with faster charging speeds, extended range and a ton of cool features has pushed the demand for EVs even higher.

However, thanks to the worldwide computer chip shortage, suppliers have been unable to meet the growing demand for electric vehicles. The situation is especially bleak in Maine, said Adam Lee, chairman of the board of Lee Auto Malls.

Electric vehicles that arrive at the the Lee car lot do not stay there long; they are gone as soon as they land at the lot at Lee Auto Mall or Rowe Auburn, Rowe salesman Agazy Abraham says, noting that consumer interest in EVs is growing every day. But despite the high demand for these quiet, high-tech cars, says Lee, the gap in supply has caught people by surprise.

He points to the ongoing global computer chip shortage as the reason for the electric vehicle shortage. And with consumers armed with tax credits and rebates designed to subsidize the relatively high cost of buying an EV, they have no choice but to wait for the computer chip supply chain to straighten itself out.

According to Lee, electric vehicles usually make up only 4% of the vehicles sold at the Lee Auto Mall. So for every 100 cars, the dealer usually only has around four EVs for sale. Since the computer chip shortage has affected the auto industry as a whole, not just the EV segment, the total number of cars on the dealer’s lot has declined, making EVs even more scarce than they already were.

For instance, Lee says, the dealer is expecting a delivery of three Nissan Leafs next month, and all three have already been purchased. The global chip shortage is preventing well-meaning drivers who would love to use less fossil fuels and help preserve the environment from getting the electric vehicles they want.

On the bright side, dealerships expect more EV and hybrid plug-in models to arrive at their lots in the near future, including the all-electric Volkswagen ID4 and the plug-in hybrid Hyundai Santa Fe. At the moment, all customers can do is place orders on the incoming EVs and sit tight until the order arrives.

The user demand shown in Maine and elsewhere across the country is a good indicator of the market that EV industry players such as Workhorse Group Inc. (NASDAQ: WKHS) have to satisfy in the coming years.

Workhorse Group Inc. (WKHS), closed Tuesday's trading session at $6.64, off by 3.6284%, on 11,615,915 volume with 58,220 trades. The average volume for the last 3 months is 11.616M and the stock's 52-week low/high is $6.0205/$42.96.

QUALCOMM Incorporated (QCOM)

The Street, InvestorPlace, MarketClub Analysis, Schaeffer's, StreetInsider, Kiplinger Today, Daily Trade Alert, MarketBeat, Zacks, The Online Investor, Trades Of The Day, Money Morning, StreetAuthority Daily, Investopedia, Barchart, StocksEarning, TopStockAnalysts, The Wealth Report, Money and Markets, Market Intelligence Center Alert, SmarTrend Newsletters, The Street Report, Louis Navellier, TheStockAdvisors,, CNBC Breaking News, Street Insider, InvestorGuide, StrategicTechInvestor, Investing Signal, The Motley Fool, Investors Alley, Top Pros' Top Picks, TheStockAdvisor, Wealth Insider Alert, Uncommon Wisdom, Daily Markets, CustomerService, Stock Gumshoe, Daily Wealth, Trading Markets, Cabot Wealth, Wealth Daily, Investing Daily, ProfitableTrading, All about trends, The Growth Stock Wire, SmallCap Network, Investor Guide, Wyatt Investment Research, Trading Concepts, GorillaTrades, The Best Newsletters, TradingMarkets, Wall Street Daily, AllPennyStocks, StreetAlerts, Investment U, Profit Confidential, Forbes, Power Profit Trades, Super Stock Investor, Total Wealth, Market FN, Daily Profit, MarketWatch, Trader Prep, FNNO Newsletters, Inside Investing Daily, Investing Futures, Agora Financial, Navellier Growth, Quant Ratings Team, SwingTradeOnline, Stockhouse, StockMarketWatch, Dividend Opportunities, InvestorsObserver Team, Leeb's Market Forecast, Market Authority and Stock Research Newsletter reported earlier on QUALCOMM Incorporated (QCOM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Shares of QUALCOMM Incorporated (NASDAQ:QCOM) traded at a new 52-week high today of $169.52. This new high was reached on below average trading volume as 2.6 million shares traded hands, while the average 30-day volume is approximately 9.6 million shares.

QUALCOMM Incorporated (NASDAQ:QCOM) is currently priced 2.1% above its average consensus analyst price target of $162.70.

Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.

Over the past year, QUALCOMM Incorporated has traded in a range of $122.17 to $169.52 and is now at $166.23, 36% above that low.

QUALCOMM Incorporated (QCOM), closed Tuesday's trading session at $166.74, up 0.536629%, on 12,353,902 volume with 151,480 trades. The average volume for the last 3 months is 10.684M and the stock's 52-week low/high is $122.165/$169.52.

The QualityStocks Company Corner

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its reverse merger transaction with Net Element is now complete. According to the update, the combined company will operate under the name Mullen Automotive Inc., with shares of Mullen Automotive now trading on the Nasdaq Capital Market under the ticker symbol MULN. “We are excited to have completed this merger and our transition to a public company and welcome the Net Element shareholders to Mullen,” said Mullen Automotive CEO and Chairman David Michery. “With the completion of this corporate action, we believe that we are well positioned to continue to further develop our electric vehicle technologies and advance the development and deployment of our previously announced vehicles.” In addition, the company announced its appointment of Dr. Marc Papakyriakou as Battery R&D Manager, Dr. George Qingyuan Hu as Vehicle Program Manager — China Operations and Jillian Green as VP of Business & Legal Affairs. “I am very pleased to have Jillian, Marc and George on board. Their expertise is a great addition to the Mullen team and comes at a crucial time for the organization, as we just listed on the NASDAQ last week through a reverse merger with Net Element Inc.,” Michery said in the news release. “Our business is scaling quickly, and we will continue to ramp up the ranks of our team as necessary.” To view the full news releases, visit and

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Tuesday's trading session at $11.02, up 7.4074%, on 995,172 volume with 5,723 trades. The average volume for the last 3 months is 995,172 and the stock's 52-week low/high is $5.72/$19.15.

Recent News

Save Foods Inc. (NASDAQ: SVFD)

The QualityStocks Daily Newsletter would like to spotlight Save Foods Inc. (NASDAQ: SVFD).

Save Foods (NASDAQ: SVFD), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced the registration of its product, SavePROTECT(TM), by the California Department of Pesticide Regulation (“CDPR”). “California is one of the most influential consumer and regulatory markets in the world, certainly the largest in the United States, so getting SavePROTECT approved by the CDPR is a major milestone for us,” said Dr. Neta Matis, the chief operation officer of Save Foods Ltd., the company’s Israeli subsidiary. “We are now free to reach out to growers, packing houses and other stakeholders that have watched our success in Mexico, Europe and Israel but needed the stamp of approval from the CDPR to use our products. We are prepared to launch our marketing and sales efforts in California immediately.” To view the full press release, visit

Save Foods Inc. (NASDAQ: SVFD) is an agri-food tech company focused on developing and selling eco-friendly products specifically designed to ensure food safety and extend the shelf life of fresh fruits and vegetables. The company is focused on addressing two of the most significant challenges faced by the industry: (1) food waste and loss, and (2) food safety.

Fungi like mold and yeast, as well as foodborne pathogens, are typically responsible for fresh produce spoilage and foodborne illness. Save Foods’ integrated solutions improve safety, freshness and quality every step of the way, from field to fork. The company’s natural products control human and plant pathogens, allowing growers, packers and food retailers to reduce waste and boost revenues. More food ends up on consumers’ plates, and less ends up in landfills.

Save Foods’ products use all-natural ingredients to protect fresh produce from microbial spoilage and pathogens with zero toxicity. The company’s treatments leave no harmful residues on produce or in the environment and maintain product freshness over time. Fresh produce treated with Save Foods’ products can already be found in supermarket chains across the U.S. and Europe. Those chains have reported that the company’s products are reducing fruit spoilage by 50% on average at the retail level. With no need for additional steps in the treatment process nor special equipment, Save Foods’ products are easy to implement and come in versatile applications suitable for the different stakeholders along the food supply chain.

Initial applications for the company’s offerings include post-harvest treatments in fruit and vegetable packing houses that process citrus, avocados, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of chemicals and their residues, Save Foods’ products not only prolong shelf life; they also ensure safe, natural and healthy food. Save Foods has the first green products that could realistically replace the different chemicals used today in food treatment while controlling waste and food safety.

Products & Technology

  • SavePROTECT or PeroStar, a processing aid added to fruit and vegetable wash water and used in post-harvest treatment;
  • SF3HS and SF3H, post-harvest treartment solutions to control both plant and foodborne pathogens;
  • SpuDefender, for controlling post-harvest potato sprouts; and
  • FreshPROTECT, for controlling spoilage microorganisms on post-harvest citrus.

Save Foods’ products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of sanitizers and fungicides at low concentrations in a non-organic setting. The combination eliminates fungicide residues or reduces them to levels below the established Maximum Residue Levels (MRLs). The company’s fruit and vegetable wash is odorless and does not irritate human eyes, skin or airways. Save Foods’ blend does not leave any residues of toxicological concern on the treated surface of produce, and all its ingredients are classified by the U.S. Food and Drug Administration (FDA) as Generally Recognized As Safe (GRAS). There are 7 patent families related to Save Foods’ technology.


The company’s products have been commercially validated on citrus, mangos, avocados, pears, bell peppers, microgreens and various fresh cut vegetables. Save Foods is in the validation process for bananas, apples, figs, berries, lettuce, papayas and more. The company is also validating the efficacy of its products for pre-harvest treatment, starting with citrus trees.

Market Outlook

The world population is expected to grow to almost 10 billion by 2050, boosting current agricultural demand by some 50%. Providing healthy and safe food for the world’s population is one of the biggest challenges of the 21st century.

Globally, around 664 million tons of fresh fruits and vegetables are lost every year from field to fork, wasted by spoilage, and almost one in 10 people globally falls ill every year from eating contaminated food, with an estimated resulting cost around $90 billion.

Disposing of all that wasted food requires additional expense and harms the environment with resulting greenhouse gas emissions. The post-harvest food treatment market was valued at $1.5 billion in 2019 and is expected to grow to $2.3 billion by 2026, achieving a CAGR of 6.5%.

Management Team

David Palach is CEO of Save Foods. He spent over a decade with Intel Israel, where his last position was Manager of Business Development for Israel and Europe. Prior to that, he served as a controller of two of Intel’s largest factories in Israel, where he supervised a budget of over $1 billion. He also served as the CEO of B-Pure Corporation Ltd., a management and maintenance company involved in protecting and improving the environment. During his tenure, he helped turn around several struggling subsidiaries and made them profitable.

Vered Raz Avayo is the company’s CFO. Before joining SaveFoods in 2018, she spent more than 10 years as CFO at LGC, the Leviev Group of Companies. She has operated her own financial and business consultancy and has served as a director for a number of public companies in Israel.

Dan Sztybel is CEO of SaveFoods Ltd., the Israeli subsidiary of Save Foods Inc. He previously led the Life Sciences Advisory at EY Israel and early on recognized the potential of Israel as a center of innovation in the digital health space. He has been an adviser on digital health strategy to large pharmaceutical companies and is a cofounder of MyndYou, a digital health start-up focusing on cognitive impairment. He is also a co-founder of the conference, the largest digital health conference in Israel.

Dr. Neta Matis is Vice President of R&D at Save Foods Ltd the Israeli subsidiary of Save Foods Inc . She holds a Ph.D. in organic chemistry and an MBA from Tel Aviv University. Prior to joining Save Foods in 2019, she held multiple research chemist and product development roles at Verdia Inc. and its parent company, Helsinki-based Stora Enso Oyj.

Nimrod Ben Yehuda is the founder and CTO of Save Foods Ltd. He was previously the CEO/CTO of Swissteril Water Purifications Ltd. He has also been CEO at Nir Ecology Ltd., and was Joint-CEO at NitroJet Ltd.

Dr. Art Dawson is the U.S. Business Manager for SaveFoods Inc. He has been president of The Dawson Company, which focuses on creating sales opportunities for new agricultural technologies, previously Dr. Dawson held senior industry positions like General Manager Worldwide of the Decco , the Post Harvest Division for Elf Atochem. He holds a Ph.D. in Plant Physiology from UC Riverside and is licensed in California as an agricultural Pest Control Advisor.

Save Foods Inc. (SVFD), closed Tuesday's trading session at $8.05, up 2.1574%, on 67,161 volume with 450 trades. The average volume for the last 3 months is 67,136 and the stock's 52-week low/high is $1.75/$30.10.

Recent News

Nemaura Medical Inc. (NASDAQ: NMRD)

The QualityStocks Daily Newsletter would like to spotlight Nemaura Medical Inc. (NASDAQ: NMRD).

Nemaura Medical (NASDAQ: NMRD), a cutting-edge medical technology company, recently conducted the beta launch of MiBoKo, a new proprietary metabolic health program designed to utilize a non-invasive glucose sensor and an AI-based mobile application. The MiBoKo application is designed to measure and monitor the user’s metabolic health scores based on glucose tolerance and insulin resistance. The cutting-edge program provides users with personalized information by tracking their metabolism when the app and sensor are used in conjunction with one another. In addition to receiving real-time updates on their metabolic health scores, MiBoKo users will be eligible to receive weekly and monthly reports illustrating the changes in their metabolic health scores as well as providing a breakdown of how individual habits were impacting their overall health and wellbeing. A recent article quotes Nemaura CEO Dr. Faz Chowdhury as saying, “With MiBoKo, we are able to extend our proprietary non-invasive device and sensor technology and interactive lifestyle and AI coaching programs beyond the traditional diabetes market and into an adjacent, yet separate, market application of metabolic health.” To view the full article, visit:

Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Its flagship product, sugarBEAT®, is a wearable, non-invasive and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and prediabetes manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading.

sugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with a smartphone app displaying glucose readings at five-minute intervals for periods of up to 24 hours. One of the great advantages of the product, apart from the fact that users no longer need to draw blood samples or prick their fingers, is that a person can wear the CGM patch on whatever day they choose. Existing CGM devices must be implanted under the skin. Wearable disposability is a unique feature of sugarBEAT and a world first, opening up vast potential for changing the way people manage their chronic disease conditions. sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union as a Class 2b Medical Device. The company submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration in 2020 which is currently under review.

Founded in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take charge of their own health and well-being. Nemaura’s skin surface blood monitoring technology has allowed the company to create additional products, which are in the pipeline, such as Lactate Monitoring.


Digital Solutions for Weight Loss and Potential Reversal of Type 2 Diabetes

This is a digital program that comes with more than a decade of clinical evidence demonstrating excellent efficacy. The company has combined this with its glucose-monitoring platform to bring a product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes.

Glucose Monitoring Solutions for Diabetes Prevention and Reversal

Over 420 million people worldwide are living with diabetes, and prediabetes cases total almost three times that number. Undoubtedly, diabetes is an urgent global health crisis. Combining clinical research with patient-friendly technology, Nemaura’s sugarBEAT product delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management.

Continuous Lactate Monitoring for Athletic Performance (Non-Medical)

Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. Well-trained athletes and those who regularly engage in sports are very efficient at faster lactate ‘recycling’ for extra energy (ATP). Nemaura expects to launch its lactate sensor to the sports and personal training market in 2022.

Continuous Lactate Monitoring in Disease State (Medical)

An increase in blood lactate levels is also a marker of critical disease states. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection. Nemaura has developed a lactate sensor that is being integrated into the company’s platform, which will be submitted for regulatory clearance upon completion of requisite clinical studies.

Continuous Temperature Monitoring for Viral Infection Detection and Disease Progression

A person’s body temperature says a lot about their health. Several diseases, including COVID-19, are characterized by an increase in body temperature, so temperature monitoring is a vital tool in the detection, diagnosis and prevention of the spread of disease. Nemaura is expecting to submit this adaptation of the device for regulatory clearance in 2022.

Market Opportunity

Obesity and diabetes are two of the major drivers of the current chronic disease epidemic. According to the International Diabetes Federation, there are more than 463 million people living with diabetes worldwide. In the U.S., about 28,000 people are diagnosed with diabetes every week, and more than 34 million suffer from diabetes. Another 88 million Americans have prediabetes. Other industrialized countries show similar numbers based on their populations. In the U.K., 4.8 million people have diabetes, with another diagnosed every two minutes. In Germany, 9.5 million have diabetes, with almost half estimated to be undiagnosed and so at greater risk.

On average, employers and insurers spend more than $9,000 annually on health care for an employee with diabetes, compared to $1,600 annually for a healthy employee. In the U.S. alone, more than $760 billion was spent on diabetes-related health care expenditures during 2019. Nemaura is positioned at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market, and the wearable health-tech sector for weight loss and wellness applications forecast to hit $60 billion by 2023.

Management Team

Dr. Faz Chowdhury has been CEO and chairman of the board of Nemaura Medical since 2013. He has more than 20 years of experience in the pharmaceutical and medical devices industry, taking products from concept to commercial launch. He is sole inventor on more than 100 granted and pending patents and has authored textbook chapters on nano-biosciences for Wiley and Elsevier. He holds a master’s degree in microsystems and nanotechnology from Cranfield University, and a doctorate from the University of Oxford in nano-medicine and drug delivery.

Justin Mclarney is CFO at Nemaura. He most recently was the Senior Director, International Finance at Lands’ End Inc. He also worked for Office Depot as Senior Director of Finance for the largest business unit within the European group. Prior to that, he spent more than 10 years in practice, the majority of which was with Ernst & Young LLP.

Dr. Fred Schaebsdau is Vice President of Strategy & Strategic Alliances at Nemaura. He has more than 15 years of executive experience in the CGM, blood glucose monitoring and insulin delivery industries, including time with Abbott Diabetes Care, as General Manager of Dexcom Germany and at Roche Diabetes Care, where he was Senior Vice-President, Head of Global Strategy and Business Development. The firm he founded is the exclusive distributor in Europe, the Middle East and Africa of UniStrip®, the world’s first generic blood glucose test strip. He is licensed to practice medicine in the U.S. and Germany.

David Scott is Director of Commercial Development and Licensing at Nemaura. He is a trained chemist with over 35 years of experience in the pharmaceutical industry, including deal brokering, marketing, strategic planning, finance, business development and acquisitions. He has also provided licensing training for a number of multinational pharma companies and training organizations and is the author of best-selling report Scrip’s Practical Guide to Pharmaceutical Licensing.

Nemaura Medical Inc. (NASDAQ: NMRD), closed Tuesday's trading session at $6.06, up 2.1922%, on 16,073 volume with 146 trades. The average volume for the last 3 months is 16,073 and the stock's 52-week low/high is $3.45/$17.40.

Recent News

Vivos Therapeutics Inc. (NASDAQ: VVOS)

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc. (NASDAQ: VVOS).

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, today announced that it plans to release financial results for the third quarter ended Sept. 30, 2021, after market close on Monday, Nov. 15, 2021. Vivos will host a conference call the same day at 5:00 p.m. Eastern Time to review the results and provide an overview of the company’s recent milestones and growth strategy. Interested parties may access a live webcast via the Vivos’ website and join the conference call by dialing (888) 394-8218 or (720) 452-9217 (international) and entering passcode 5806322. A replay and online archive of the webcast will be available shortly after the call. To view the full press release, visit

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. (NASDAQ: VVOS) is an emerging global leader in the treatment of mild-to-moderate obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to rid the world of mild-to-moderate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of mild-to-moderate sleep apnea often caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established contract manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are among the leading causes of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective treatment for the estimated hundreds of millions of people globally who suffer from mild-to-moderate OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that studies have shown to be associated with sleep-disordered breathing—including mild-to-moderate OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,200 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in the treatment of mild-to-moderate OSA since CPAP.

The Vivos System has been specifically designed to promote the proper growth and development of the hard and soft tissues surrounding and comprising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which together form and shape the upper airway. As these areas develop more fully using the Vivos System, a patient’s airway typically widens and expands, enabling them to breathe properly through their nose. With a more open and less obstructed airway, and easier nocturnal breathing, the symptoms of SDB tend to diminish over time, and patients often report they no longer suffer from the adverse effects of SDB or OSA.

Use of the Vivos System is variable and case dependent, but typically recommended to be worn daily for 12 to 16 hours starting in the early evening and continuing overnight. The total treatment time typically ranges from 12 to 24 months, with 18 months being the approximate mean treatment time.

Biomimetic Oral Appliance

Vivos Therapeutics believes that the Vivos System technology represents the first non-surgical, non-invasive and cost-effective treatment for people with mild-to-moderate OSA.

Combining technologies and protocols that can alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA.

The Vivos System treatment is typically less than $10,000 and is often reimbursable by medical insurance as an out-of-network benefit.

A potentially serious medical problem with an alternative treatment therapy available in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically enhanced using the proprietary Vivos® System devices and clinical protocols.


R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.

Vivos Therapeutics Inc. (NASDAQ: VVOS), closed Tuesday's trading session at $3.93, up 0.255102%, on 39,478 volume with 324 trades. The average volume for the last 3 months is 39,478 and the stock's 52-week low/high is $2.61/$14.41.

Recent News

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF).

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has completed the acquisition of Ketamine Wellness Centers Arizona LLC ("KWC"). The completion firmly establishes Delic as the largest chain of wellness centers that provide ketamine treatments in the United States. Delic now offers access to new medicines and treatments through 12 operational clinics spread across 10 states, including Arizona, Colorado, Florida, Illinois, Minnesota, Nevada, Texas, Utah. The company anticipates opening 15 additional clinics in the next 18 months. In addition, Kevin Nicholson, KWC CEO, was appointed chief operating officer at Delic. The acquisition brings KWC’s team of 60-plus medical professionals and ‎employees to Delic, which is focused on offering increased access to science-backed benefits for all and reframing the psychedelic conversation. The company accomplishes this through an array of businesses aimed at scaling the impact and reach of treatment, including 1) the largest and most accessible network of physical clinics to administer effective treatments, 2) a licensed lab to develop IP, R&D and innovative high-quality and safe product lines, and 3) trusted media and e-commerce platforms and in-person events to market services directly to patients and consumers. “We are thrilled to officially welcome the KWC team to the Delic family and cement our place as the largest network of treatment clinics in the U.S.,” said Delic CEO and cofounder Matt Stang in the press release. “With the addition of KWC, we can now reach millions of people suffering from various mental health conditions who have lost hope of finding effective, affordable treatments. As more treatments, such as MDMA and psilocybin, become FDA-authorized for medical use, we have the potential to help millions more people through the clinics." To view the full press release, visit

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Inc. (DELCF), closed Tuesday's trading session at $0.177, up 2.8998%, on 106,144 volume with 57 trades. The average volume for the last 3 months is 106,144 and the stock's 52-week low/high is $0.1293/$1.038.

Recent News

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF)

The QualityStocks Daily Newsletter would like to spotlight First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF).

First Energy Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, has announced the results of drill hole LC21-14 at its Augustus Lithium Property; the property  is located in Quebec, Canada. According to the announcement, the drill hole intersected a 4.5-meter-wide zone with 1.43 percent (%) lithium oxide (Li 2 O) at 115.5 meters drilled depthAccording to the announcement, highlights of the study include average lithium oxide values within the mineralized intersection in the range of 0.26% to 2.15% Li2O with an average of 1.43% Li2O over 4.5 meters at 115.5 meters, as well as lithium values in the range of 1,220 parts per million (ppm) to 10,000 ppm and beryllium in the range of 67 ppm to 246 ppm, cesium (Cs) 12.8 ppm to 53 ppm, niobium (Nb) 5.7 ppm to 128.9 ppm, rubidium (Rb) 46.8 ppm to 446 ppm, and tantalum (Ta) 12.6 ppm 115 ppm. Other key things to note include the fact that the lithium pegmatite intersection has lower iron values in the range of 0.41% to 0.58% and the drill indicated smaller lower-grade lithium pegmatites intersections, specifically 0.6% Li2O over one meter at 107 m drilled depth and 0.54% Li2O over one meter at 127.5 m drilled depth. The company noted that all samples were bagged and tagged using best practices; samples were delivered to Activation Laboratories, an independent commercial, accredited ISO certified laboratory located in Ancaster, Ontario, for sample preparation and analysis. To view the full press release, visit

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) is a publicly traded Canadian mineral exploration company. Its primary focus is on developing a multi-commodity mineral property portfolio by identifying, acquiring and exploring North American mineral prospects in the precious metal, base metal and industrial metals sectors.

Headquartered in Vancouver, the company (formerly known as “Agave Silver”) was first incorporated on October 12, 1966.

Core Properties – Augustus Lithium and Titan Gold

Located in Landrienne & Lacorne-Townships, Quebec, Canada, in an active lithium exploration/mining area, the Augustus Lithium Property and surrounding claims total 14,367.71 hectares . It is equipped with excellent infrastructure support, including a road network, railway, electricity, water and trained manpower available locally.

Other highlights of the Augustus Lithium Property include:

  • Geologically similar to Sayona Mining’s Authier Lithium project and Mine Quebec Lithium project located 6-12 km away.
  • Documented historical drilling over 10,000m in 62 drill holes, worth over $2 million in present day exploration expenditures.
  • Two prominent lithium and one silver prospects located on the property.
  • A potential high grade lithium resource target of 4 million tonnes at 1% lithium oxide (Li2O).
  • Potential for large volume low grade bulk tonnage near surface.
  • Two phase exploration work program includes: data compilation, geological mapping, trenching and sampling in Phase 1 (estimated cost $191,418) and diamond drilling, metallurgical testing and resource estimation in Phase 2 (estimated cost $1,166,963).

The Titan Gold Property is located in the Detour-Fenlon Greenstone Belt of east-central Quebec and is comprised of 80 mining claims totaling 4,334 hectares.

Other highlights of the Titan Gold Property include:

  • The Detour-Fenlon Greenstone Belt is host to the Detour Mine containing 20 million ounces of gold. The Fenlon Project of Wallbridge Mining has also reported strong high-grade gold intercepts and a successful high-grade (18.49 g/t Au) bulk sample.
  • Hosted within a structurally active geological environment with several northwest trending deformation zones which are splays off the Sunday Lake Deformation Zone – all key ingredients to the gold mineralization in the area.
  • The property has seen little historical exploration yet sits within what is becoming a prolific recognized gold camp.

Non-Core Properties – Kokanee Creek Gold and Scramble Mine Properties

The Kokanee Creek Gold Property consists of three mineral claims covering approximately 1,590.29 hectares in the Nelson Mining Division in British Columbia.

Other highlights of the Kokanee Creek Gold Property include:

  • Gold mineralization indicated in surface samples from historical work since 1979.
  • Subsurface gold mineralization discovered in drill holes.
  • Continuity of mineralized zones indicated through geological mapping, geochemical and geophysical survey.
  • Past producing mines in the vicinity, including the Molly Gibson and the Alpine deposits.
  • Historical production reported for the Molly Gibson Mine from 1909-1940 was at an average grade of 36.1 g/t Au and 15.3 g/t silver, with recent exploration returning samples running up to 270 g/t Au.
  • Revived exploration on the Alpine deposit area has reported a 2018 inferred resource of 142,000 oz at 16.52 g/t Au using a cut-off grade of 5.0 g/t.

First Energy Metals also holds an option to acquire a 100% interest in the Scramble Mine Gold property, located approximately 8 km east of the town of Kenora in Northwestern Ontario. The mine was discovered in 1894 but remained essentially dormant until 1984, when Boise Cascade Canada Ltd. commenced an evaluation of the property. Since 1984, approximately 5,200 meters of diamond drilling, 250 meters of surface stripping with sampling and 450 meters of underground development have taken place at the property.

Other highlights of the Scramble Mine Property uncovered as part of the company’s 2020 prospecting and sampling programs include:

  • Average value of gold in surface samples is 29.34 grams per tonne (1.03 ounces per tonne).
  • Gold assays ranged from 5.03 grams per tonne (0.18 oz/t) to 82.30 grams per tonne (2.90 oz/t), with two samples assayed over 2 oz/t.
  • All samples assayed over 5 grams per tonne gold.

Market Outlook

The global precious metals market was valued at $193.3 billion in 2020 and is expected to grow at a CAGR of 9%, resulting in a market valuation of $362.1 billion by 2027 (

The global lithium metal market was valued at $534.6 million in 2020. Through 2027, it is expected to grow at a CAGR of 9.6%, resulting in a forecast valuation of $926.6 million (

First Energy Metals is well positioned to leverage growth opportunities in these expanding sectors through exploration of both its core and non-core properties.

Management Team

Gurminder Sangha is the Chief Executive Officer and Director of First Energy Metals Ltd. He is experienced in the financial industry, focusing on providing advisory-level services to privately and publicly traded companies. Mr. Sangha brings over 18 years of diverse experience related to financial management, business leadership and corporate strategy to his role with First Energy Metals. During his tenure as a board member for various publicly traded companies, he has led initiatives related to corporate finance, business development and corporate governance. Mr. Sangha has an MBA from both Queens University and Cornell University.

Jurgen Wolf is the Chief Financial Officer and Corporate Secretary for First Energy Metals Ltd. He has been involved in the oil and gas industries for over 15 years, assisting public companies with administration and investor relations. Mr. Wolf was educated in Germany and immigrated to Canada in 1953. From 1958 to 1982, he owned and operated pre-cast concrete factories in Calgary and Vancouver. From 1982 to 2002, Mr. Wolf owned and operated J.A. Wolf Projects Ltd., a commercial construction company. He is the previous President and Director of the former US Oil and Gas Resources Inc., which amalgamated to form Petrichor Energy Inc. in 2005. Mr. Wolf retains director roles with several public companies.

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF), closed Tuesday's trading session at $0.167, up 2.8009%, on 39,949 volume with 8 trades. The average volume for the last 3 months is 39,949 and the stock's 52-week low/high is $0.087/$0.4572.

Recent News

StraightUp Resources Inc. (CSE: ST)

The QualityStocks Daily Newsletter would like to spotlight StraightUp Resources Inc. (CSE: ST).

StraightUp Resources (CSE: ST) (OTCQB: STUPF), a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America, has started trading on the OTCQB Venture Market in the United States under the symbol STUPF. The company noted that its common shares will also continue to trade on the Canadian Securities Exchange (“CSE”) under the symbol ST. The OTCQB exchange is designed for early-stage and developing companies. StraightUp Resources anticipates that the OTCQB listing will result in greater exposure, visibility and trading convenience for its U.S. investors. “Upgrading to the OTCQB provides a greater reach in today’s marketplace, one that transcends borders and is truly global,” said StraightUp Resources president and CEO Mark Brezer in the press release. “The new listing gives StraightUp improved access to millions of U.S. investors during our next phase of growth and ultimately, connects us with a much larger audience. I expect our shareholders to benefit through increases in trading liquidity and expanded retail and institutional investors.” To view the full press release, visit

StraightUp Resources Inc. (CSE: ST) is a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America. The company’s flagship properties are located in the Red Lake Mining District of Ontario, Canada, renowned for over 30 million ounces of historic gold production. Other key projects extend into the neighboring Meen-Dempster Greenstone Belt of the Uchi Subprovince. The company’s management team is led by dedicated professionals, aiming to maximize shareholder value while employing modern exploration techniques and principles to achieve its goals.

The mission of StraightUp Resources is to maximize shareholder wealth through mineral discoveries at projects with robust potential, maintain long-lasting partnerships, and continue to focus on the acquisition, development and exploration of mineral resource properties in North America. The company’s objective is to continue to locate and develop economic, precious and base metal properties of merit.

The company’s 10,000-hectare (almost 25,000 acres) RLX Projects are contiguous to various Evolution Mining, Great Bear Resources, Pacton Gold and Dixie Gold properties. Its 2,000-hectare (just under 5,000 acres) Belanger Project is contiguous to Infinite Ore’s Fredart and Garnet/Arrow properties. StraightUp intends to conduct exploration on the RLX North, RLX South, Belanger and Ferdinand Gold properties located in the Red Lake District, a location touted as having one of the best metal-endowed greenstone belts in the world. The Bear Head Gold Project is located within the Meen-Dempster Greenstone Belt of the Uchi Subprovince, approximately 80 kilometers west of the Pickle Lake Gold Camp and 14 km northeast of the former gold mine, Golden Patricia. It amassed 620,000 ounces of gold at an average of 15.2 g/t Au from 1988-1997. The property is bordered by an Australian miner massive gold project. Known gold occurrences are already mapped on the Bear Head property, as are previous drill holes and results. Once the data is re-examined, an exploration budget and subsequent plans will be announced by the company.


Ontario’s Red Lake Mining District is one of Canada’s most prolific gold mining districts, renowned for its high-grade gold deposits. This is a mining-friendly, politically stable jurisdiction with a skilled labor force and infrastructure specifically built around meeting the needs of the mining industry.

RLX North & South Projects
At over 10,000 hectares, the RLX North and RLX South Projects represent a district-scale exploration opportunity. The RLX North and RLX South Projects are well positioned on-strike to the southeast of the district’s largest gold deposit (Red Lake Gold Mines – Evolution Mining). The project is adjacent to Great Bear Resources’ Sobel Project. Great Bear Resources is also in the process of evaluating the area for significant regional-scale structural controls and has proposed additional work on its neighboring project in the near term. These properties are highly accessible, with the southern boundary only eight kilometers from the paved highway into Red Lake, and can be accessed by forest service roads which traverse throughout the properties.

Belanger Project
Historic exploration work on the 2,000-hectare property has identified three significant surface exposures of gold, copper and silver. Early exploration work will focus on validating historic sampling results and following the occurrences along strike with a view to better understanding the nature and controls on mineralization. The property has excellent forest road access from the town of Ear Falls.

Ferdinand Gold Project
The Ferdinand property is situated within the southeastern extension of the Confederation-Uchi greenstone belt, one of the most metal-endowed greenstone belts in the world by square kilometer. It consists of 17 contiguous mining claims covering approximately 7,143 hectares (17,650 acres), located 13 kilometers northwest of the town of Slate Falls. Access is currently by logging roads, with forestry logging operations scheduled for expansion on the property. StraightUp recently completed a heliborne magnetic survey consisting of 1,994 line-km at 50m line spacings covering the entire property. The MAG survey was designed to provide geological and structural details of a 25km long southeast extension of the Confederation-Uchi greenstone belt along the Fry-Bamaji Deformation Zone.

Bear Head Gold Project
The Bear Head Gold Project comprises 31 mining claims totaling 1,944 hectares (4,800 acres) in the Meen-Dempster Greenstone Belt of the Uchi Subprovince, host to the Golden Patricia former gold mine, which produced 620,000 ounces of gold from 1988 to 1997. The Dorothy Main gold deposit owned by Ardiden lies only one kilometer from the Bear Head Gold Project. The Dorothy Main gold deposit holds noncompliant historical resources of 46,600 ounces of gold at 6.17 g/t Au. The company looks forward to adding the Bear Head Gold Project to its exploration efforts, with a work program to be conducted later in the fall of 2021.

Management Team

Mark Brezer is CEO, President, and Director of StraightUp Resources Inc. He is a successful businessman and holds a Geography/Geology degree from the University of Arizona. He has worked as a Project Manager and has overseen quality control, environmental monitoring and safety programs related to road construction. He has also held roles in media relations and marketing. He has been actively involved in the research and investment of junior mining companies for over 25 years. Time in the field and personal interest led him into extensive first aid training, and he is certified as a paramedic and firefighter.

Daniel Cruz is CFO and Director at StraightUp Resources. He is an experienced financial industry professional, having worked for 12 years as a senior investment advisor at Canadian broker-dealers, where he gained experience in equity research, asset management, investor relations, corporate finance and venture capital. He was one of the youngest Senior Investment Advisors at Canaccord Financial Inc. in 2010. He is also the co-founder and current director of Liquid Media Group Inc., a Nasdaq-listed issuer. During his tenure as CFO, he helped that company list on Nasdaq and raise over $20 million.

Matthew Coltura is a Director at StraightUp Resources. He has a Bachelor of Business Administration from Okanagan College, where he specialized in finance. He has worked in the finance industry for more than three years. Currently, Mr. Coltura is the CFO of Cayenne Capital Corp. He was also a director of PreveCeutical Medical Inc. from July 2016 to September 2019, a director of Sproutly Canada Inc. (formerly Stoneridge Exploration Corp.) from March 2015 to July 2018, and, since March 2018, has worked as a financial specialist at Quip Finance.

StraightUp Resources Inc. (CSE: ST), closed Tuesday's trading session at $0.162, even for the day, on 200 volume. The average volume for the last 3 months is 685 and the stock's 52-week low/high is $0.1211/$0.27.

Recent News

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)

The QualityStocks Daily Newsletter would like to spotlight Red White & Bloom Brands Inc. (OTCQX: RWBYF).

Cannabis research has been hampered by federal law for decades. Only one institution, the University of Mississippi, has been allowed by the Drug Enforcement Administration (DEA) to cultivate cannabis for research purposes, and researchers have long said that the plant material provided by the university is subpar and does not measure up to the cannabis sold in dispensaries across the country. With some studies finding that this cannabis is often contaminated by mold in many cases, industry stakeholders have argued that the DEA needs to approve more cultivators. Now a new study has revealed what most cannabis researchers already suspected: the cannabis grown at the country’s only federally authorized source is genetically akin to hemp. Once additional manufacturers/growers are licensed, the future research done will stand a chance of giving findings that closely represent the effects of marijuana products made by industry actors such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) rather than those that aren’t reflective of the reality lived by consumers.

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is a torchbearer blazing a new frontier in American cannabis by adhering to the highest ethical, manufacturing, educational, branding and employment standards available in the industry.

Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multi-state operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further.

Although targeting individual states in the United States, the company is headquartered in Toronto, Canada. Red White & Bloom was established after privately held MichiCann Medical Inc. merged with publicly traded Tidal Royalty in 2019.


Red White & Bloom has entered strategic brand acquisitions and partnerships aimed at helping the company expand its presence and position as one of the largest players in the United States cannabis market. Red White & Bloom is always diligently searching for brands to acquire that will provide additional value to the company and expand its national footprint.

The company’s current brand portfolio includes:

  • Platinum Premium Cannabis Products (PV): Platinum uses innovative thinking, honesty and responsibility to remain at the forefront of the cannabis industry. PV holds itself and its partners to the highest standards, providing clean and safe CBD and THC products. In the company’s press release dated January 13, 2021, it reported system-wide sales of Platinum-branded products exceeding $2.8 million for the first week of January alone.
  • High Times®: In June 2020, the company acquired the licensing rights and branding of High Times dispensaries and High Times cannabis-based CBD and THC products in Michigan, Illinois and Florida. The company also acquired branding of High Times hemp derived CBD products nationally in the United States carrying the Culture® brand.
  • Mid-American Growers: Mid-American began as a family operation in 1971 in Granville, Illinois. The original 8-acre greenhouse has expanded to a 3.6-million-square-foot, state-of-the-art technology and science facility under glass. Mid-American’s product offerings include its CBD Icy Relief Salve, CBD Icy Relief Roll-on and CBD Gummies.

Retail Focus

Red White & Bloom is working to establish a significant retail presence across multiple jurisdictions. In Michigan, the company is invested in and has the rights to acquire (subject to regulatory approvals) a licensed operator that controls the assets of 18 dispensary locations throughout the state. Red White & Bloom is also pursuing opportunities in Florida aimed at making its proposed retail footprint compelling and attractive to the majority of cannabis consumers within each state.


Red White & Bloom is focused on standardization and quality, with everything guided by a relentless commitment to the highest standards. The company acquired a 3.6-million-square-foot standardized facility dedicated to helping it achieve premium value for the products it intends to cultivate.

As it continues to expand, the company remains committed to the practices that have guided its success in the past, including:

  • A top-down approach to cultivation developed under the guidance of PhDs with expertise in growing principles, SOPs and, most importantly, the science behind it all.
  • Commitment to exceeding the requirement of the states in which it operates. The company cut its teeth under the world’s first national cannabis purity regime – a regime that most new markets use as a benchmark – so quality is in its DNA.
  • Science-driven production methods supported by automated, perpetual, standardized operations that enable craft cannabis-like quality at an industrial scale.


Assuming completion of the currently proposed investments and acquisitions, Red White & Bloom will be among the cannabis market’s largest companies, joining the ranks of a select few multi-state operators dominating the industry. Red White & Bloom currently has assets (closed and in closing stages) in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts.

The company’s strategic acquisition and super state operator model, combined with its commitment to top-quality product and service, position it to become a leading player in the North American cannabis market.

When evaluated beside competitors in the cannabis space, Red White & Bloom boasts an extremely attractive valuation. While large cap cannabis firms serving North American markets averaged enterprise-value-to-EBITDA multiples of 14.9x as of December 2020, Red White & Bloom’s enterprise multiple was just 3.4x, as noted in the company’s latest investor deck.

In 2020, the cannabis market worldwide was valued at $24.6 billion. This amount is expected to expand at a CAGR of 14.3% from 2021 to 2028, resulting in a market size of $84 billion in 2028 ( Of the 2020 valuation, the largest revenue share (91.1%) was attributed to North American consumers (

Management Team

Brad Rogers is the CEO and Executive Chair of Red White & Bloom. He is a visionary for the future of cannabis and CBD products in the United States market, with a proven track record of building successful and profitable businesses in the rapidly expanding and new economic sector. Mr. Rogers was a part of the team that built one of the first commercially scaled production facilities in the world for medicinal cannabis. He also served as President for one of the leading licensed producers in Canada. Both of his ventures were successful, with a combined market cap of $2 billion.

Michael Marchese is the company’s Co-Founder and Marketing Advisor. He has played a crucial role in its development and organization, overseeing capital raises, acquisition strategy and brand identity. Mr. Marchese has a strong reputation and presence in the cannabis industry. He also co-founded and directed the branding of Aleafia Health Inc., which he continues to counsel. Through his branded company, Marchese Design, he has served as a highly trusted counselor to top-level execs, including C-Suite level employees, offering insights into the process of creating, building and maintaining brand identities.

Theo van der Linde is the CFO and Director of Red White & Bloom. He is a Chartered Accountant with 20 years of experience in finance, administration and public accounting. The experience he has acquired spans multiple industries, including mining, oil & gas, financial services, retail and manufacturing. For the last nine years, he has primarily focused his career on the mining industry, working with junior exploration and producing mining companies at various stages of growth in several jurisdictions. Mr. van der Linde is also the current President of Executive Management Solutions Ltd.

Red White & Bloom Brands Inc. (RWBYF), closed Tuesday's trading session at $0.5199, off by 2.9675%, on 288,423 volume with 157 trades. The average volume for the last 3 months is 288,423 and the stock's 52-week low/high is $0.405/$1.65.

Recent News

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)

The QualityStocks Daily Newsletter would like to spotlight PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF).

  • Plant-based wellness brand builder PlantX Life is expanding its footprint, adding a brick-and-mortar store in San Diego to its flagship store in British Columbia
  • PlantX Life celebrated the San Diego store’s grand opening Oct. 30 with a variety of plant-based brand builders, including the popular food innovator Beyond Meat
  • The San Diego store has more than 4,500 square feet of retail and café space, as well as an education center with resources for increasing consumer awareness
  • PlantX Life’s digital presence includes a weekly podcast series, YouTube channel videos, an informative blog and an e-commerce portal accessible through Walmart’s and Amazon’s marketplaces
  • The company intends to open a third store in Israel in November with a website focused on consumers in that part of the world
  • PlantX Life’s first year-end financial report in July stated the company’s gross revenues had grown to $6.58 million as of March 31

American multinational food processing and commodities trading giant Archer-Daniels-Midland (“ADM”) recently released its second annual list of global consumer trends, highlighting the plant-based lifestyle in its No. 2 position with a note that COVID-19 “has accelerated interest in plant-based (nutrition), as a health-forward alternative for consumers who are paying close attention to their body’s nutritional needs” (

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more.

PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including:

  • An easy-to-use e-commerce shopping experience featuring the following:
    • Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
    • Meal delivery with recipes created by well-known plant-based chefs throughout the world
    • Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
    • Easy to follow plant-based recipes every week
    • Partnerships with restaurants, nutritionists, chefs and brands
    • A community of like-minded individuals
  • State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home.

Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community.

The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). The company’s common shares are eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States.

Market Outlook

With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020.

Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%.

PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries.

Digital Platform for the Plant-Based Community

The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings.

PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

  • Shop
  • Find recipes
  • Read blogs
  • Join a community forum
  • Listen to podcasts
  • View cosmetics
  • Research vitamins
  • Purchase plant-based pet foods
  • Read corporate updates
  • Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine.

PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel

PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition.

These PlantX branded flagship locations will first launch in:

Customer engagement, education and creating a global plant-based community will be furthered through this initiative.

PlantX Restaurant Partnerships

With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier.

PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus.

Future Goals for PlantX Life

Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel.

Verticals launched in 2020 include:

  • New meals and programs by renowned chefs
  • Flagship PlantX locations
  • PlantX branded goods
  • United States meal delivery and LIV
  • Online peer-to-peer fitness

Management Team

Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk.

Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles.

Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception.

Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), closed Tuesday's trading session at $0.3, off by 1.6716%, on 130,089 volume with 112 trades. The average volume for the last 3 months is 130,089 and the stock's 52-week low/high is $0.17/$1.85.

Recent News

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)

The QualityStocks Daily Newsletter would like to spotlight Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF).

Eating disorders such as anorexia and binge eating are serious illnesses characterized by damaging and complex relationships with body image, exercise, food and eating. Individuals suffering from binge eating disorder usually experience recurrent episodes, which involve the consumption of huge amounts of food, feeling they have lost control and experiencing feelings of shame or guilt after the binge. This disorder can cause obesity if it remains untreated, which in turn leads to other severe health issues, including gallbladder disease and type 2 diabetes. Experts recommend that individuals eat three square meals about three to four hours apart, with snacks in between. Additionally, it is recommended that you get professional help to stop overeating and begin your recovery from binge eating disorder. In the foreseeable future, the professional help could take the form of novel medicines developed by entities such as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to deliver superior clinical outcomes.

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) is a pharmaceutical company focused on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathways.

The company was founded in 2019 and is headquartered in San Diego, California.

Innovative Drug Pipeline

Tryp’s current focus is on advancing its two drug development platforms: its Psilocybin-for-Neuropsychiatric Disorders (PFN™) program targeting fibromyalgia, eating disorders and chronic pain conditions; and razoxane for soft tissue sarcomas. The company intends to explore opportunities to monetize these platforms after generating Phase 2b clinical data.

The company’s development plans cover three strategic initiatives:

  • Develop: Tryp intends to utilize the FDA’s 505(b)(2) regulatory pathway with available third-party preclinical data to shorten the timelines and lower the cost of its development programs.
  • Protect: Tryp plans to utilize regulatory exclusivity, patents, trade secrets and proprietary know-how to protect the commercial lifespan of its drug candidates.
  • Monetize: Tryp intends to seek out licensing, acquisition and co-development opportunities for drug candidates following their Phase 2 stages of development.

PFN™ Program

Through its PFN™ program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that have distinct advantages over other drugs currently on the market or in development. These advantages include:

  • Increased efficacy
  • Natural blood-brain barrier penetration
  • Enhanced safety and toxicity profiles
  • Reduced risk of abuse
  • Reduced risk of addiction

Tryp’s PFN™ program features its lead drug candidate, TRP-8802. The company’s initial indication for TRP-8802 is fibromyalgia.

Fibromyalgia is believed to be a neurosensory disorder characterized in part by abnormalities in pain processing by the central nervous system. The three drugs with FDA approval for the treatment of fibromyalgia are Pregabalin (Lyrica®), Duloxetine (Cymbalta®) and Milnacipran (Savella®), which are only effective for a portion of patients suffering from the condition.

Tryp plans to seek FDA approval to proceed directly to Phase 2 clinical trials evaluating TRP-8802 as a treatment for fibromyalgia based on existing preclinical and clinical data for the active pharmaceutical ingredients in TRP-8802.

Tryp’s pipeline of indications for TRP-8802 also includes eating disorders and certain forms of chronic pain. The company expects to initiate Phase 2a clinical trials in these areas in 2021.

Tryp recently partnered with Albany Molecular Research Inc. (“AMRI”) for the manufacture of the company’s synthetic psilocybin using proprietary methods. AMRI has initiated the process of manufacturing a 200g non-GMP demonstration batch of psilocybin and will produce a batch of GMP psilocybin in mid-2021. As the holder of the Drug Master File, Tryp expects to be the only U.S.-based manufacturer of synthetic psilocybin in the industry.


Tryp’s second drug candidate, TRP-1001 (razoxane), is being developed as a treatment for soft tissue sarcomas and has been evaluated in multiple Phase 2 clinical trials conducted by clinicians unaffiliated with Tryp. The company believes that existing clinical data regarding razoxane will likely allow TRP-1001 to be studied in a Phase 2 trial without the need for extensive preclinical or Phase 1 trials.

Sarcomas are rare tumors that are derived from connective tissues in the body and comprise 7% of all cancers in children. In 2018, an estimated 13,000 new cases of soft tissue sarcoma were diagnosed, with the tumors resulting in over 5,000 deaths during that year in the United States alone (

Market Outlook

With its drug development programs targeting multiple indications, Tryp is well positioned to capitalize on growth opportunities spanning a range of therapeutic markets. The global oncology drugs market, in particular, represents a sizable opportunity.

In 2018, oncology indications accounted for 25% of all drug sales, representing approximately $151 billion in market revenues. By 2024, spending on oncology-targeted therapeutics is expected to top $200 billion and account for roughly 30% of total drug sales, according to a study by Cowen Equity Research (

Valued at $764 million in 2020, the global fibromyalgia treatment market presents unique opportunities for development due to the limited number of approved therapies. With treatment trending upward, the market is expected to grow at a CAGR of 9.2% and reach $1.4 billion in value by 2027 (

Management Team

Greg McKee is the Chairman and CEO of Tryp Therapeutics. He has more than 20 years of life sciences management and venture investment experience that he brings to the company. Before taking his role at Tryp, he was the founder of Torrent Ventures, an early-stage digital health and medical technology venture fund. Mr. McKee also served as the CEO of CONNECT, the largest Southern California start-up accelerator. Before this, he was the chairman, president and CEO of then publicly traded Nventa Biopharmaceuticals, which successfully merged with Akela Pharma. Mr. McKee earned a B.A. in Economics from the University of Washington, an M.A. in International Studies from The Joseph H. Lauder Institute, and an MBA from the Wharton School at the University of Pennsylvania. He has been a member of the Young President’s Organization (YPO) since 2006.

James Gilligan, Ph.D., is the company’s President and Chief Science Officer. He has over 35 years of experience in the life sciences industry, including research and development, clinical development, international regulatory affairs and manufacturing. Before joining Tryp, Dr. Gilligan was the Co-Founder and Managing Partner of The Bracken Group, a life sciences consulting firm. He was also the Co-Founder of Unigene Laboratories, which develops technology for the recombinant manufacture of peptide hormones. Dr. Gilligan received his Ph.D. in Pharmacology from the University of Connecticut and a MSIB from Seton Hall University. He continued his post-graduate education at the Roche Institute of Molecular Biology.

Tom D’Orazio is the Chief Operating Officer of Tryp Therapeutics. He has extensive experience in leading the development and commercialization of vaccines, drugs, radiopharmaceuticals and biologics. His prior leadership experience has been in commercial planning, marketing, partnership and business development roles. He was formerly the CEO of ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), where he led the transition from a private company to a public one. He co-founded and served as CEO of Superna Life Sciences, a specialty-pharma company focusing on niche drugs for cancer patients in Canada. Mr. D’Orazio has an MBA from Vanderbilt University with a primary focus in both finance and marketing and a B.Sc. in chemistry from Loyola University of Chicago.

Luke Hayes is the company’s Chief Financial Officer. He has played an active role in the life science industry for over 20 years with technology transfer, venture capital and finance experience. His career started with business development for Dow Chemical (NYSE: DOW), with responsibility for pharmaceutical customers such as Eli Lilly and AbbVie. Mr. Hayes has spent more than a decade doing venture capital investing while supporting companies as a director and advisor. He earned a B.S. in Chemical Engineering from Brigham Young University and an MBA from the UCLA Anderson School of Management.

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), closed Tuesday's trading session at $0.2898, off by 1.1259%, on 64,371 volume with 31 trades. The average volume for the last 3 months is 64,371 and the stock's 52-week low/high is $0.2687/$1.04.

Recent News

DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF)

The QualityStocks Daily Newsletter would like to spotlight DigiMax Global Inc. (CSE: DIGI) (OTCQB: DBKSF).

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. DigiMax’s CEO Chris Carl joined the latest episode to discuss the company’s history and business model focused on applying AI across various industries and verticals. “As we rolled forward, because we also have financial backgrounds, we were interested in how we could better use blockchain, security tokens and efficiency of markets that results from those. As we worked through that, we saw an opportunity to get involved in artificial intelligence, and that really was a game changer for us,” Carl said in the interview. “Last year, we acquired two small artificial intelligence companies — small in size, but not in terms of depth. The result is that DigiMax is an artificial intelligence company using AI in the world of fintech, blockchain, crypto and even other applications that aren’t as razzle dazzle as the crypto world.” To view the full press release, visit

DigiMax Global Inc. (CSE: DIGI) (OTCQB: DBKSF) is an artificial intelligence technology and services company producing and leveraging predictive indicators across various industries and verticals.

The company offers financial, business, and human capital AI predictive solutions to businesses, institutions, and consumers to improve decision-making.

The DigiMax core solutions are:

  1. CryptoHawk AI – CryptoHawk is a deep learning AI solution (SaaS) that monitors and analyzes live select cryptocurrencies and financial markets. The CryptoHawk AI solution is offered to retail clients as a monthly subscription. Generated data provides subscribers with price trend predictions for better investment strategies.
  2. Cryptocurrency Hedge Fund – A long/short cryptocurrency hedge fund for high net worth, institutional, and family office clients was launched on September 1, 2021. The company’s crypto hedge fund earns clients’ management and overall performance fees.
  3. Projected Personality Interpreter (PPI) – DigiMax solutions utilize AI to provide comparative insights for better hiring decisions, reduced employment attrition, improved workplace culture, and augmented human and financial predictive services by measuring and correlating personal attributes.
  4. Navee Predict – DigiMax data scientists provide companies with the unprecedented power of enhancing decision-making by analyzing, detecting changes and forecasting patterns.

The company’s team has extensive experience in finance, trading, machine learning (ML), neural language processing, AI, big data, and cryptocurrency technology. DigiMax leverages AI and its expert team to translate data into actionable predictive insights across the financial, business, and human dimensions, enhancing the decision-making capacity of organizations. DigiMax is an official IBM Watson partner with more than 30 years in data science and artificial intelligence.


Business and Financial Capital Solutions

CryptoHawk AI is a cryptocurrency price and trend prediction solution offered as a web application ( and a mobile application by the end of 2021. The value for the user is to capture gains and take advantage of volatility while reducing risk and engaging in smarter and simpler trading.

The key features:

  • Trend Prediction Indicator (“TPI”)
    The TPI is a superior model that leverages the cryptocurrencies analyzed by the AI and other market-driven data and policies to produce actionable predictions in the form of:
    • Prediction cards
    • Cryptocurrency graphs with optional market indicators
    • Email/SMS alerts
  • Trend Watch
    Trend Watch is a one-week look ahead machine learning prediction for a select portfolio of mature cryptocurrencies. Trend Watch predicts a trend being UP or DOWN and provides a price target. Users have access to:
    • A list of select cryptocurrencies with predictive graphs

The system alerts investors through email and text messages when a price trend changes, allowing users to act confidently.

Cryptocurrency Hedge Fund

On September 1, 2021, DigiMax launched its Cryptocurrency Hedge Fund to offer high net worth, institutional, and family office clients a fully systematic long/short active investment into a basket of cryptocurrencies capitalizing on crypto volatility and powered by proprietary trading algorithms. The official launch is expected in the coming months.

The fund is led by 40-year hedge fund veteran Ian Hamilton and has an experienced investment and fund management team. This actively managed fund provides an excellent opportunity for larger investors to gain exposure to cryptocurrencies.

AI Business Prediction as a Service

The company offers predictive insights to businesses through automation and its innovative and proprietary AI and ML technology. Traditional models are expensive, because they are created and developed by data scientists dedicated to solving specific business questions that require costly customization and weeks, if not months, of development. With DigiMax, companies have access to solutions and services at a fraction of the price of traditional and experimental approaches. By combining AI with ML prediction technology, the company delivers insights on:

  • Sales forecasts
  • Optimal inventory levels
  • Supply chain management
  • Invoice payment projections
  • Targeted segmentation for marketing campaigns

Human Capital Solutions

AI-Powered Projected Personality Interpreter

The Projected Personality Interpreter (“PPI”) evaluates and improves customers’ workforce, brand and culture by revealing the personality traits and sentiment buried in human expression. The PPI empowers organizations with comparative insight for better hiring decisions, reducing employment attrition and improving workplace culture.

PPI provides a comprehensive and complete solution, offering:

  • Recruitment campaign management
  • Custom questionnaires, desirable traits recipes, and group likenesses
  • Detailed personality reports to compare and contrast peers
  • API for advanced integration with alternative systems of record

DigiMax leverages IBM Watson and a custom algorithm that analyzes applicant responses across 52 different traits and compares those scores with a baseline, providing hiring managers with a comprehensive report that improves decision making and takes the bias out of the process. The company’s solution is currently in use by 17 law enforcement agencies in North America and is used across the 10 global recruitment brands of Shepherd Search Group.

Market Overview

The AI industry has a five-year CAGR of 18.4%, with revenues projected to reach $37.9 billion by 2024. Some more optimistic forecasts have the market worth as much as $15 trillion by 2030. It’s estimated that 80% of all emerging technologies in 2021 have AI foundations. About 40% of all businesses use AI in their operations. According to Industry Ark, artificial intelligence use in the recruitment market was valued at $580 million in 2019.

Management Team

Chris Carl, CEO

Chris Carl has over 20 years of experience as a public-company CEO and has built several successful businesses across multiple categories. He has a proven ability to lead and has a track record of execution, revenue growth, and value creation.

Thierry Hubert, CTO

Thierry Hubert has 30 years of technology experience with Fortune 100 companies worldwide and is an early pioneer in applying artificial intelligence to solve big data and unstructured information challenges with IBM as a Director of R&D in emerging technology, knowledge management, and process innovation. He has received awards, recognitions, and grants that contributed to his ongoing collaboration with industry leaders.

David Bhumgara, CFO

David Bhumgara is a senior finance executive with over 25 years of leadership experience and proven expertise in finance, financial reporting, accounting, corporate finance, budgeting, financial modeling, and mergers & acquisitions.

Damon Stone, Trading Strategy Advisor

Damon Stone is an experienced stock and crypto trader who works very closely with the data science team as a subject matter expert. During 15 years at Merrill Lynch as a market maker and proprietary trader, he traded many different sectors, culminating in heading up a $250 million trading desk.

Ross Power, Senior Innovation Engineer
Ross Power is an experienced technical system architect with a demonstrated history of working on advanced technologies, including AI algorithms, IoT solutions, 3D printing, Innovation in BCI (Brain-Computer Interfacing), and RC flight and navigation systems.

DigiMax Global Inc. (DBKSF), closed Tuesday's trading session at $0.0884, off by 6.8395%, on 18,000 volume with 9 trades. The average volume for the last 3 months is 18,000 and the stock's 52-week low/high is $0.05/$0.70.

Recent News

Moon Equity Holdings Corp. (OTC: MONI)

The QualityStocks Daily Newsletter would like to spotlight Moon Equity Holdings Corp. (MONI).

Moon Equity Holdings (OTC: MONI) is focused on investing in a well-diversified acquisition portfolio of income-generating businesses looking to produce long-term gains. Precious metals are a vital component of MONI’s growing portfolio and, as such, the company is closely watching developments in the space. Although the economic uncertainty of the past 18 months has impacted this space by causing prices to fluctuate wildly, the forecast looks fairly good according to a recent article that contains excerpts from a publication by Forbes, cited as an aggregate of expert opinions in the industry. “All signs point to gold cooling down and consolidating in the short run before rallying again toward the end of the year and into 2022,” reported the article, noting that Citigroup predicts a price target of $2,500 by year end and that gold prices would most likely surge if the Fed was forced to raise the federal funds rate to combat rising inflation. Forbes also stated that an increase in demand for silver is likely, stemming primarily from the Biden’s administration’s $2 trillion climate plan.” In addition, according to the Forbes article, industry analysts believe the industrial demand for precious metals within the platinum group, including rhodium, ruthenium, osmium, iridium, palladium, and platinum, is high and showing no signs of slowing down. “All this bodes well for Moon Equity Holdings, a company that recently rebranded to reflect a revised business strategy.” To view the full article, visit

Moon Equity Holdings Corp. (OTC: MONI) is an investment company that focuses on acquisitions in the fintech, crypto, precious metals and real estate sectors. The company’s goal is to enhance the profitability of these acquired companies, which in turn will increase shareholder value. Moon Equity Holdings’ philosophy is to provide its shareholders with a well-diversified acquisition portfolio focused on income-generating strategies that produce long term gains.

The company has been working on a crypto component in development, along with two trademarked products that will revolutionize how people gift and purchase cryptocurrency. With this, Moon Equity Holdings will use decentralized technology to enhance customer experience. First-rate service is the cornerstone of Moon Equity Holdings’ success. The company’s focus on best-in-class customer service is expected to create a loyal brand following and generate repeat business.

Business Operations

Moon Equity Holdings Corp. acquired Royal Costino LLC as a wholly owned subsidiary for its newly created Mining Division. Its primary business is processing, buying, selling and exporting precious metals. This acquisition completes the first step of the two planned mining acquisitions for this year. The acquisition is expected to significantly enhance revenue for the company, generating an estimated $2 million per month in additional income. Royal Costino’s facility has been in operation since 2013, and its team has more than 30 years of experience in this field.

Management Team

Moon Equity Holdings Corp. has assembled a highly skilled and experienced management team.

Alison Galardi is the CEO of Moon Equity Holdings Corp. Before joining the company, she gained more than 20 years of experience at Fortune 100 financial services companies, including Spear Leeds & Kellogg, TIAA-CREF and Citigroup, where she held positions in global banking, institutional sales, trading and investor relations.

Anthony Cappaze is head of Moon Equity Holdings’ Mining Division with more than 30 years of mining experience. He was founder and CEO of Royal Sovereign Costino prior to its acquisition by Moon Equity Holdings Corp.

Advisory Board

Sue Ferrari is a Senior Industry Principal that has over 20 years of experience in innovation, insights and analytics across technology, financial services and media, including VP, Bank of NY Mellon and ADP.

Maureen Vizvary worked at Microsoft, HP and Xerox launching innovative products and developing marketing campaigns that rebrand entire organizations. During her tenure at Microsoft, she served on the advisory team restructuring Microsoft’s mid-market sales division and developed award-winning, cutting-edge technology to transform the way hospitals interact with patient information.

Colleen Cline has over 33 years’ experience in the financial services and insurance industries, including sales, marketing, business development and management. She worked with Fifth Third Bancorp and Allstate Insurance, receiving various industry awards in sales, marketing and customer satisfaction. She is also an entrepreneur and top performer in the health care and wellness industry.

Moon Equity Holdings Corp. (OTC: MONI), closed Tuesday's trading session at $0.0459, off by 1.9231%, on 1,658,180 volume with 70 trades. The average volume for the last 3 months is 1.658M and the stock's 52-week low/high is $0.0013/$0.14654.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading